India is rapidly growing with large presence in global pharmaceuticals. It is the largest provider of generic medicines globally. India ranks third worldwide for production by volume and 14th by value. India is the only country with largest number of US-FDA compliant Pharma plants. India has more than 2000 WHO-GMP approved Pharma Plants, 253 European Directorate of Quality Medicines (EDQM) approved plants with modern state of the art Technology.

India is the source of 60,000 generic brands across 60 therapeutic categories and manufactures more than 500 different Active Pharmaceutical Ingredients (APIs).

The cost of manufacturing in India is much lower than that of the US

India’s online pharmacy market is gaining momentum at a high speed which will be phenomenally beneficial for Pharma Companies to have set-up in India.

Investment in India

Greenfield Pharma:

As per the present Reserve Bank of India guidelines, 100% Foreign Direct Investment (FDI) is allowed under the automatic route for.

Brownfield Pharma:

100% FDI is allowed i.e. 74% is allowed under the automatic route and thereafter through government approval route